Skip to main content
AkademIndex

Products

For developers

AkademBaseOpen API for the ecosystem
← Back to work

Works cited by this work

361 works

Work: Epigenetic mechanisms and next-gen editing platforms in hematology: From molecular basis to therapeutic frontiers

  1. Unveiling the potential of CLL-1: a promising target for AML therapy

    Hamed Soleimani Samarkhazan, Sara Zehtabcheh, Hamideh Rahmani Seraji +4

    Review article20256 citations
    ABI

  2. Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors

    Enli Liu, David Marín, Pinaki P. Banerjee +24

    Article20206 citations
    ABI

  3. Aqueous and ethanolic extracts of Moringa oleifera leaves induce selective cytotoxicity in Raji and Jurkat cell lines by activating the P21 pathway independent of P53

    Leila Rajabi, Mostafa Ebrahimdoost, Seyed Amin Mohammadi +3

    Article20255 citations
    ABI

  4. Modified lentiviral globin gene therapy for pediatric β0/β0 transfusion-dependent β-thalassemia: A single-center, single-arm pilot trial

    Shiqi Li, Sikai Ling, Dawei Wang +17

    Article20245 citations
    ABI

  5. CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells

    Levi J. Rupp, Kathrin Schumann, Kole T. Roybal +4

    Article20174 citations
    ABI

  6. Platelet-derived extracellular vesicles: emerging players in hemostasis and thrombosis

    Aziz Kubaev, Fadhil Faez Sead, Mohammad Pirouzbakht +6

    Review articleExtracellular vesicles in diseaseJournal of Liposome Research20254 citations
    ABI

  7. Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression

    Lei S. Qi, Matthew H. Larson, Luke A. Gilbert +4

    Article20133 citations
    ABI

  8. Delivering CRISPR: a review of the challenges and approaches

    Christopher A. Lino, Jason C. Harper, James P. Carney +1

    Review article20183 citations
    ABI

  9. Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    Stephen J. Schuster, Michael Bishop, Constantine S. Tam +21

    Article20183 citations
    ABI

  10. Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

    Shannon L. Maude, Theodore W. Laetsch, Jochen Buechner +32

    Article20183 citations
    ABI

  11. CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy

    Kevin Pan, Hizra Farrukh, Veera Chandra Sekhar Reddy Chittepu +3

    Review article20223 citations
    ABI

  12. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells

    Yanfang Fu, Jennifer A Foden, Cyd Khayter +4

    Article20132 citations
    ABI

  13. Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage

    Nicole M. Gaudelli, Alexis C. Komor, Holly A. Rees +4

    Article20172 citations
    ABI

  14. The CRISPR tool kit for genome editing and beyond

    Mazhar Adli

    Review article20182 citations
    ABI

  15. TRAPT: a multi-stage fused deep learning framework for predicting transcriptional regulators based on large-scale epigenomic data

    Guorui Zhang, Chao Song, Mingxue Yin +6

    Article20252 citations
    ABI

  16. CRISPR-engineered T cells in patients with refractory cancer

    Edward A. Stadtmauer, Joseph A. Fraietta, Megan M. Davis +38

    Article20202 citations
    ABI

  17. Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells

    Sangya Agarwal, M. Ángela Aznar, Andrew J. Rech +17

    Article20232 citations
    ABI

  18. Epigenetic frontiers: miRNAs, long non-coding RNAs and nanomaterials are pioneering to cancer therapy

    Rajkumar Prabhakaran, Rajkumar Thamarai, Sivabalan Sivasamy +6

    Review article20242 citations
    ABI

  19. “Galectin-9: A double-edged sword in Acute Myeloid Leukemia”

    Omolbanin Sargazi-Aval, Ali Ahmadi, Ali Jihad Hemid Al-Athari +5

    Review article20252 citations
    ABI

  20. Insights into KMT2A rearrangements in acute myeloid leukemia: from molecular characteristics to targeted therapies

    Sara Zehtabcheh, Hamed Soleimani Samarkhazan, Marjan Asadi +3

    Review article20252 citations
    ABI

  21. C-type lectin-like molecule-1 as a diagnostic, prognostic, and therapeutic marker in leukemia

    Hamed Soleimani Samarkhazan, Sara Zehtabcheh, Sajjad Peyvasteh +1

    Review article20252 citations
    ABI

  22. Nanotechnology in leukemia therapy: revolutionizing targeted drug delivery and immune modulation

    Ashok Kumar Bishoyi, Sina Nouri, Ahmed Hussen +3

    Review article20252 citations
    ABI

  23. Non-homologous DNA end joining and alternative pathways to double-strand break repair

    Howard H. Chang, Nicholas R. Pannunzio, Noritaka Adachi +1

    Review article20172 citations
    ABI

  24. Epigenetic Therapeutics: A New Weapon in the War Against Cancer

    Nita Ahuja, Anup Sharma, Stephen B. Baylin

    Review article20162 citations
    ABI

  25. The Long Noncoding RNA MEG3 and its Target miR-147 Regulate JAK/STAT Pathway in Advanced Chronic Myeloid Leukemia

    Zi-ye Li, Lin Yang, Xiaojun Liu +3

    Article20182 citations
    ABI